Two Catalysts For Axovant Sciences In March
Two Catalysts For Axovant Sciences In March.....»»
Gilead Sciences (GILD) Q1 Earnings Top Estimates
Gilead (GILD) delivered earnings and revenue surprises of 8.64% and -0.49%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock? Want the latest recommendations from Zack.....»»
PRA Health Sciences (PRAH) Surpasses Q1 Earnings Estimates
PRA Health Sciences (PRAH) delivered earnings and revenue surprises of 3.77% and -1.49%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock? Want the latest recommendations from Zacks In.....»»
Gilead’s CFO to step down early next year
Foster City-based Gilead Sciences/ longtime chief financial officer is planning her exit. Robin Washington, the biopharmaceutical giant’s executive vice president and CFO, intends to retire from her role by March 1, 2020, the company said. “Dur.....»»
Eric Schmidt, Diane Greene exiting Alphabet"s board
Alphabet Inc. said on Tuesday that its former CEO and chairman, Eric Schmidt, and former Google Cloud CEO Diane Greene are leaving its board of directors. Robin Washington, who is retiring as chief financial officer of Gilead Sciences next March, is.....»»
Gilead"s CFO, appointed to Google parent"s board, to retire
Gilead Sciences Inc. said late Tuesday Chief Financial Officer Robin Washington plans to retire in March 2020. Washington will continue as CFO while the company searches for a replacement, Gilead said. If Gilead names a CFO before March 2020, Washington .....»»
Gilead"s CFO, appointed to Google parent"s board, to retire
Gilead Sciences Inc. said late Tuesday Chief Financial Officer Robin Washington plans to retire in March 2020. Washington will continue as CFO while the company searches for a replacement, Gilead said. If Gilead names a CFO before March 2020, Washington .....»»
Why Shares of Plug Power Skyrocketed 34% in March
A range of catalysts helped power this fuel cell leader's stock higher this month......»»
Liberty Health Sciences: Stock Catalysts In The Lead
Liberty Health Sciences: Stock Catalysts In The Lead.....»»
1 High-Yield Dividend Stock to Consider Buying Before March Ends
This pipeline giant has quite a few catalysts coming in April......»»
SELLAS Life Sciences Reports 2018 Financial Results and Provides Business Update
NEW YORK, March 22, 2019 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) ("SELLAS" or the "Company"), a clinical-stage biopharmaceutical company focused on the.....»»
The Daily Biotech Pulse: Arsanis Completes X4 Merger, EC Nod For Roche, Axovant Offering
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on March 13) read more.....»»
Mid-Day Market Update: NASDAQ Rises Over 100 Points; Axovant Sciences Shares Surge
Midway through trading Monday, the Dow traded up 0.16 percent to 25,512.72 while the NASDAQ climbed 1.37 percent to 7,522.91. The S&P also rose, gaining 0.85 percent to 2,772.23. Leading and Lagging Sectors read more.....»»
Stocks That Fell to 3-Year Lows in the Week of March 8
Gilead Sciences, CVS Health, Walgreens and Vodafone reach multiyear lowsRelated Stocks: GILD, CVS, WBA, VOD,.....»»
Axovant Sciences hires CMO of Allergan to join Axovant as EVP of R&D
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Axovant Sciences: Breaking Down What"s Seemingly Broken For Further Insight
Axovant Sciences: Breaking Down What"s Seemingly Broken For Further Insight.....»»
Axovant Sciences appoints Fraser Wright, PhD as Chief Technology Officer
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Axovant Sciences licenses OXB-102 from Oxford BioMedica
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
UPDATE: Axovant shares soar 51% premarket on $842.5 mln licensing pact for Parkinson"s treatment
Shares of Axovant Sciences Ltd......»»
Axovant Sciences, Oxford BioMedica agree to $842.5M OXB-102 license agreement
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Axovant Sciences to hold a conference call
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»